Contraception

Impact of Levonorgestrel Intrauterine System versus Copper IUD on menstrual changes and uterine artery Doppler indices: a randomized clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201701001900640

Enrollment

300

Registered

2016-12-01

Start date

2016-12-12

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Contraception

Interventions

Group I (Levonorgestrel IUS):

Group II (Copper IUD):

LNG-IUS

Group I (Levonorgestrel IUS)

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women requesting long-acting reversible contraception (LARC) who fulfilled the criteria for IUD insertion.

Exclusion criteria

Exclusion criteria: Pregnancy, undiagnosed genital bleeding, breastfeeding, previous genital infection in the preceding 3 months, medical disorders and any contraindication to IUD insertion or progestin administration.

Design outcomes

Primary

Measure	Time frame
menstrual changes and changes in uterine artery Doppler indices after 3 and 6 months of use.	—

Secondary

Measure	Time frame
: adverse effects of the method and patient acceptability.	—

Countries

Egypt

Contacts

Public ContactMohamed Rezk

Lecturer of Obstetrics and Gynecology-Faculty of Medicine-Menoufia University

m_rezk9207@yahoo.com00201006237186

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Mar 4, 2026